www.alk.net
  • Patients
    • What is allergy
      • House dust mite allergy
      •  
      • Pollen allergy
      •  
      • Living with allergy
      •  
      • Socio-economic impact
      •  
    •  
    • What is allergic asthma
    •  
    • How is allergy diagnosed
    •  
    • Treating allergy
    •  
  •  
  • Healthcare Professionals
    • Treating allergy and asthma
    •  
    • Products
    •  
    • Adverse reactions
    •  
    • Initiation of treatment
    •  
    • Clinical trials
    •  
  •  
  • R&D
    • R&D pipeline
    •  
    • Understanding immunotherapy
    •  
    • Research
    •  
    • Congress activities
    •  
    • Clinical data sharing
    •  
  •  
  • Careers
    • Working at ALK
    •  
    • Vacant positions
    •  
  •  
  • Investors
    • Overview
    •  
    • Financial reporting
      • Risk management
      •  
      • Reporting standards
      •  
      • Auditors
      •  
    •  
    • Governance
      • IR policy
      •  
      • Management
      •  
      • Board of directors
      •  
      • Annual general meeting
      •  
      • Annual general meeting (DK)
      •  
    •  
    • News & Events
      • Company Releases
      •  
      • Company releases (DK)
      •  
      • Webcasts & presentations
      •  
      • Investor calendar
      •  
    •  
    • The Share
      • Dividend history
      •  
      • Analyst coverage
      •  
      • Analyst estimates
      •  
      • Shareholder information
      •  
      • Authorizations
      •  
      • ADR Programme
      •  
    •  
    • Contact IR
    •  
    • Management
    •  
    • Board of directors
    •  
    • AGM
    •  
    • AGM (DK)
    •  
    • Nyheder
    •  
    • Nyheder (EN)
    •  
  •  
  • Media
  •  
  • About
    • ALK at a glance
    •  
    • CSR
    •  
    • Production
    •  
    • Global presence
    •  
    • Organisation
    •  
    • History
    •  
    • Values
    •  
    • Owners
    •  
  •  
  • Select country
  •  
Search

News release

Links: 
Company Releases
Company releases (DK)
Webcasts & presentations
Investor calendar

« Back

Annual General Meeting in ALK-Abelló A/S held on 18 March 2021

March 18, 2021

PDF Version

ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF): ALK-Abelló A/S held its Annual General Meeting on 18 March 2021.

The Annual General Meeting transacted the following business:

  • Adoption of the annual report 2020 and discharge of the Board of Directors and Board of Management

  • No declaration of ordinary dividend

  • Adoption of the remuneration report for 2020

  • Adoption of the remuneration to the Board of Directors for the present year

  • Re-election of Anders Hedegaard as the Chairman of the Board of Directors

  • Re-election of Lene Skole as the Vice Chairman of the Board of Directors

  • Re-election of Lars Holmqvist, Jakob Riis and Vincent Warnery as well as new election of Gitte Aabo and Bertil Lindmark to the Board of Directors

  • Re-appointment of PwC Statsautoriseret Revisionspartnerselskab as the company’s auditor

  • Adoption of the following proposals from the Board of Directors:

    1. Authorisation for the Board to hold fully electronic general meetings

    2. Preparation etc. of corporate announcements and documents for internal use by the general meeting in English

    3. Indemnification of the Board of Directors and Board of Management

    4. Update of the remuneration policy

ALK-Abelló A/S


For further information please contact:
Anders Hedegaard, Chairman, tel. +45 4574 7576

Attachment

  • FM_09_21UK_18032021
  • Email Alerts

    Email Alerts

  • Downloads

    Downloads

  • RSS

    RSS

  • Print

    Print

  • Share

    Share

  • English

    English

  • Search

    Search




Select Country Menu

  • Change Country

Quick Links

  • Contact us
  • News
  • Media
  • Vacant jobs
  • Products

ALK Footer Copyright Text

ALK-Abelló A/S ∙ Bøge Allé 6 ∙ DK-2970 Hørsholm ∙ Denmark ∙ CVR no. 63717916 ∙ T +45 45 74 75 76 Legal disclaimer © ALK ∙ All rights reserved